CIK: 1465278 - Address: C/O Regulus Therapeutics Inc., 4224 Campus Point Court #210, San Diego, CA 92121
34 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret212-6-11-16-8-15-72-21
P%wins00505050025
S%ret115-0-4-15-14-9-16-10
S%wins6080100601008080

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/18/24 20:22
1/18/24
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOCEOS-171.190-15-2057D
5/23/23 17:18
5/18/23
AUPHAurinia Pharmaceuticals Inc.HealthDrugPharmaceutical PreparationsHagan Joseph PA0DM.d00.000927112D
5/23/23 17:18
5/19/23
AUPHAurinia Pharmaceuticals Inc.HealthDrugPharmaceutical PreparationsHagan Joseph PA0DS.d-310.5800-212D
1/26/22 16:13
1/26/22
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOP.d220.2152010032417D
1/4/22 16:17
1/3/22
AUPHAurinia Pharmaceuticals Inc.A0HealthDrugPharmaceutical PreparationsHagan Joseph PA1DM.d2035.080404D
1/4/22 16:17
1/3/22
AUPHAurinia Pharmaceuticals Inc.A0HealthDrugPharmaceutical PreparationsHagan Joseph PA1DS.d-90422.590-40-924D
5/17/21 19:13
5/17/21
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-40.89000-4-1316D
4/16/21 16:11
2/16/21
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS.a-71.720-4-2245D
2/17/21 17:23
2/16/21
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-71.720-4-1486D
11/18/20 16:09
11/16/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-30.52110-6-3216D
8/17/20 20:22
8/14/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-30.60490-4-2222D
5/18/20 16:28
5/15/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-30.62670-4-2226D
2/19/20 18:09
2/18/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-40.83040-4-2231D
1/3/20 16:07
1/2/20
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-80.96670-8-3235D
11/15/19 17:36
11/14/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-40.64000-6-2243D
10/2/19 18:17
10/1/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-60.68270-9-3249D
8/16/19 16:17
8/15/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-20.55060-4-2258D
7/2/19 17:42
7/1/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-81.310-6-2262D
5/16/19 17:25
5/16/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS.d-481.220-39-13268D
5/8/19 17:15
5/7/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOP.d361.0803310665D
4/3/19 16:31
4/1/19
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOS-60.98100-6-1631D
7/25/17 18:08
7/25/17
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCADOP,CEOP2000.91000220999%241D
3/7/16 17:20
3/3/16
RGLSRegulus Therapeutics Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOCOOP727.191010New10D-37-66-22-26122464-6-135-27-64-92
9/15/14 15:11
9/15/14
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOSVP,CorpP234.69356213D-1-23-26-124-10-11-12-5-8-371235-51
8/2/13 19:34
7/31/13
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuM.d201.661120D357473224251914-11-4-10-33-10-35
8/2/13 19:34
7/31/13
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuS.d-947.801-12-1000D357473224251914-11-4-10-33-10-35
7/29/13 19:49
7/26/13
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuM.d171.661100D349322918182320130-1-5-28-13-34
7/29/13 19:49
7/26/13
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuS.d-747.401-10-1000D349322918182320130-1-5-28-13-34
5/30/13 17:38
5/28/13
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuM.d461.661280D127873118376-1-3-7-83-5-1
5/30/13 17:38
5/28/13
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuS.d-1967.001-28-1000D127873118376-1-3-7-83-5-1
7/13/12 20:13
7/13/12
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuM.d501.663300D192872576598622495-11-43-17-12-15
7/13/12 20:13
7/13/12
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuS.d-2036.773-30-1000D192872576598622495-11-43-17-12-15
6/29/12 18:58
6/27/12
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuM.dm1791.6621080D402732693065755145-44-73-53
6/29/12 18:58
6/27/12
OREXOrexigen Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsHagan Joseph PCAOChief BuS.dm-5975.532-108-1000D402732693065755145-44-73-53

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact